Clinical Trials for Cancer | Advanced Cancer Treatments | CancerCareE
info@cancercaree.com +86 182 1759 2149 (China)
English Русский العربية Türkçe
Online Evaluation
Home > Treatments > Clinical Trials
Access to Cutting-Edge Treatments

Clinical Trials for Cancer

Access the latest cancer clinical trials worldwide. Find opportunities for advanced treatments including CAR-T therapy, Gamma Delta T-cell therapy, TIL therapy, and more.

Get Free Consultation Browse Trials
Expert Medical Team
Verified Clinical Trials
Global Network
Patient-Centered Care

Active Clinical Trials

Browse our curated list of active clinical trials for various cancer types and treatments

CAR-T Trial for B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 2
Recruiting
Location: China
Hospital: Beijing Hematology and Oncology Hospital
Phase 2 clinical trial evaluating the efficacy and safety of CAR-T therapy in patients with B-cell acute lymphoblastic leukemia who have not responded to standard treatments.
Eligibility Criteria: Age 18-70 years, confirmed B-ALL diagnosis, no response to at least two lines of therapy
Start: Oct 2023 More Information
CAR-T Therapy for Non-Hodgkin Lymphoma
Phase 3
Recruiting
Location: China
Hospital: Tianjin Cancer Center
Phase 3 clinical trial comparing CAR-T therapy with standard chemotherapy in patients with relapsed or refractory non-Hodgkin lymphoma.
Eligibility Criteria: Confirmed non-Hodgkin lymphoma diagnosis, relapse after initial treatment, age over 18 years
Start: Nov 2023 More Information
TIL Therapy for Metastatic Melanoma
Phase 2
Recruiting
Location: USA
Center: National Cancer Institute
Phase 2 trial evaluating Tumor-Infiltrating Lymphocyte (TIL) therapy in patients with metastatic melanoma who have not responded to immunotherapy.
Eligibility Criteria: Confirmed metastatic melanoma, no response to standard immunotherapies
Start: Sep 2023 More Information
Gamma Delta T-Cells for Multiple Myeloma
Phase 1/2
Recruiting
Location: China
Hospital: Shanghai University Hospital
Phase 1/2 clinical trial evaluating the safety and efficacy of Gamma Delta T-cell therapy in patients with treatment-resistant multiple myeloma.
Eligibility Criteria: Treatment-resistant multiple myeloma, age 18-75 years, adequate organ function
Start: Aug 2023 More Information
Combination Immunotherapy for Breast Cancer
Phase 2
Completed
Location: Turkey
Hospital: American Hospital Istanbul
Clinical trial evaluating the combination of immunotherapy and chemotherapy in patients with metastatic triple-negative breast cancer.
Eligibility Criteria: Triple-negative breast cancer, metastatic disease, no prior treatment for metastatic disease
Completed: Jun 2023 Study Results
Targeted Therapy for Non-Small Cell Lung Cancer
Phase 3
Recruiting
Location: Germany
Center: Heidelberg Cancer Center
Phase 3 clinical trial comparing a new targeted therapy with standard chemotherapy in patients with non-small cell lung cancer with EGFR mutations.
Eligibility Criteria: Metastatic non-small cell lung cancer, positive EGFR mutation, no prior treatment for metastatic disease
Start: Jul 2023 More Information
0
Active Trials
0
In China
0
Patients Enrolled
0
Participating Countries

Clinical Trials in China

China has become a global leader in cancer clinical trials, with a particular focus on advanced treatments like CAR-T, Gamma Delta T-cells, TIL, and NK therapies.

Leading Chinese hospitals such as Beijing Hematology and Oncology Hospital, Tianjin Cancer Center, and Shanghai University Hospital are at the forefront of cancer research.

Participating in clinical trials can provide access to innovative treatments that are not yet widely available, offering new hope for many cancer patients.

Get Free Consultation
Clinical Trials in China - Advanced Cancer Treatments

Clinical Trial Activity: US vs China (2014–2024)

Clinical Trial Activity US vs China - Cancer Research Comparison

How to Read This Chart

  • The U.S. currently hosts a larger share of registered cancer clinical trials (historical advantage in early-stage biotech & immuno-oncology).
  • China's share is growing rapidly since 2021, especially in CAR-T and cell therapy trials.
  • Registered trial counts are a proxy for R&D capacity, not direct measure of efficacy.
  • Both countries show increasing investment in cancer clinical trial development.

Data note: counts aggregated from clinical trial registries and literature review (2014–2024).

United States — Strengths

  • Larger number of registered trials and advanced-phase studies
  • Stringent regulatory oversight and transparent reporting
  • Infrastructure for complex personalized treatments
  • Established research ecosystem with academic-industry collaborations

China — Strengths

  • Rapid development timelines and increasing cell therapy capacity
  • Competitive costs for treatment and participation
  • Several innovative CAR-T and cell therapy programs
  • Growing government support for clinical research

Latest Clinical Trial Advances

CAR-T Trials Show Promise in Solid Tumors

Recent clinical trials demonstrate that CAR-T therapy can be effective against certain solid tumors, with new approaches overcoming previous limitations in the tumor microenvironment.

Nature Medicine, 2024 Phase I/II Results

Gamma Delta T-Cell Therapy Advances

Clinical trials of Gamma Delta T-cell therapies show promising results in hematologic malignancies and some solid tumors, with improved safety profiles compared to traditional CAR-T.

Blood, 2024 Multi-center Trial

Combination Approaches Enhance Efficacy

Research continues to demonstrate that combination therapies work best in clinical trials, particularly immunotherapy combinations that create synergistic anti-tumor effects.

Cancer Discovery, 2024 Preclinical & Clinical

Frequently Asked Questions

Who can participate in clinical trials?
Each clinical trial has specific eligibility criteria based on factors like cancer type and stage, previous treatments, overall health, and specific genetic markers. Our specialists can help determine if you qualify for specific trials.
What are the benefits of participating in clinical trials?
Benefits include access to new treatments before they are widely available, close monitoring by medical experts, and the opportunity to contribute to medical research that may help future patients.
Are clinical trials safe?
Clinical trials follow strict protocols to ensure patient safety. All treatments are thoroughly tested in preclinical studies before human trials, and participants are closely monitored throughout the process.
What costs are associated with clinical trials?
In many cases, the study sponsor covers the cost of the experimental treatment and related tests. However, routine care costs and travel expenses may not be covered. We help patients understand all potential costs before participation.

Find the Right Clinical Trial for You

Our specialists can help match you with appropriate clinical trials based on your specific cancer type, medical history, and treatment goals. Get personalized guidance throughout the process.

Schedule Your Free Consultation